Published in Eksp Klin Farmakol on December 13, 2007
Intracellular redox state as target for anti-influenza therapy: are antioxidants always effective? Curr Top Med Chem (2014) 0.77
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Etiological characteristics of the influenza epidemics of 2006-2009 in the Russian Federation (according to the data of the Research Institute of Influenza, North-Western Branch, Russian Academy of Medical Sciences)]. Vopr Virusol (2010) 0.81
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models]. Vopr Virusol (2010) 0.78
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk (1998) 0.75
[Detection of nucleotide sequences specific for retroviruses in Saccharomyces cells]. Genetika (1987) 0.75
[Interleukin-2 and cancer immunotherapy]. Vopr Onkol (1989) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
[The membranotropic and neurotropic properties of remantadine and deitiforin in experimental models]. Vopr Virusol (1991) 0.75
[Regulation of expression of the htpR gene in Escherichia coli]. Mol Biol (Mosk) (1987) 0.75
[Anti-HIV activity of complex isoborneol ethers]. Dokl Akad Nauk (1992) 0.75
[Molecular chaperones: new proteins--new functions]. Mol Biol (Mosk) (1992) 0.75
No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses. Dokl Biol Sci (2007) 0.75
[Immunomorphological changes in the mouse brain after intracerebral administration of a neurotropic strain of influenza virus]. Biull Eksp Biol Med (1991) 0.75
[Actinomycin D binding with the DNA of some transplantable tumors]. Dokl Akad Nauk SSSR (1971) 0.75
[Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk (1994) 0.75
[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Synergism of processes of generating active forms of oxygen and proteolysis as a possible reason for developing influenza]. Dokl Akad Nauk SSSR (1991) 0.75
[The effective use of superoxide dismutase from human erythrocytes in the late stages of experimental influenza infection]. Vopr Virusol (1992) 0.75
[Detection in the structure of influenza viral proteins of sequences similar to vasoactive intestinal peptide]. Biull Eksp Biol Med (1991) 0.75
[Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine]. Eksp Klin Farmakol (2007) 0.75
[Differences in the buoyant density of mitochondria from hepatoma, Krebs ascitic tumor II and normal liver]. Vopr Onkol (1975) 0.75
[Effect of homologous nuclear RNA and infectious RNA of the Venezuelan equine encephalitis virus on the biosynthesis of RNA and protein in isolated rat liver mitochondria]. Biokhimiia (1974) 0.75
[Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol (1997) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[Lymphokine-like activity in a culture of cells of the embryonal human brain and in the cerebrospinal fluid]. Fiziol Zh SSSR Im I M Sechenova (1988) 0.75
[Several properties of the nucleic acide of nuclei and mitochondria from hepatoma induced by N-nitroso-N-diethylamine]. Vopr Onkol (1975) 0.75
[Bird flu as a global biocatastrophe (editorial)]. Ter Arkh (2006) 0.75
[Electron transport chain in the isolated nuclei and nuclear membranes of the rat liver]. Biokhimiia (1974) 0.75
[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Epizootics of "avian" influenza as the manifestation of pandemic]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.75
[Compatibility of mitochondrial ribosomes with matrix RNA of nuclear origin]. Dokl Akad Nauk SSSR (1973) 0.75
[Isolation of an individual mRNA from mitochondria, its reverse transcription and characteristics of the complementary DNA]. Dokl Akad Nauk SSSR (1978) 0.75
[Polyadenylic acid sequence in viral RNA]. Vopr Virusol (1976) 0.75
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[The effect of oxygen free radicals on the viability of strains of Saccharomyces with various levels of expression of the metallothionein gene]. Dokl Akad Nauk SSSR (1989) 0.75
[The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol (1997) 0.75
[Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek (2006) 0.75
[The origin of mitochondrial RNA in animal tissues. 4. Post-transcriptional RNA modification and polyribosome formation in isolated mitochondria]. Mol Biol (Mosk) (1976) 0.75
[Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol (1998) 0.75
[The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk (1993) 0.75
[Genetic defect in ceruloplasmin synthesis in liver polyribosomes in Wilson-Konovalov disease]. Dokl Akad Nauk SSSR (1975) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[An analysis of the potential areas of recombination in the hemagglutinin genes of animal influenza viruses in relation to their adaptation to a new host--man]. Vopr Virusol (1994) 0.75
[ Influenza virus proteins modulate hemostasis in vitro and in vivo ]. Izv Akad Nauk Ser Biol (2004) 0.75
[Physicochemical characteristics of the products of virus-specific syntheses in isolated mitochondrial]. Dokl Akad Nauk SSSR (1973) 0.75
[Oligomeric forms of recombinant interleukin-2]. Biokhimiia (1991) 0.75
[Replication of infectious viral RNA in isolated mitochondria. 1. Penetration of vital RNA into mitochondria and its effect on mitochondrial synthesis]. Vopr Virusol (1972) 0.75
Origin of the mitochondrial RNA of animal tissues. 2. Hybridization with nuclear DNA. Mol Biol (1974) 0.75
[Molecular mechanisms of selecting influenza virus strains by signs of drug resistance]. Dokl Akad Nauk SSSR (1991) 0.75
The origin of mitochondrial RNA of animal tissues studied by hybridization with mitochondrial DNA. Mol Biol (1973) 0.75
[The possibility of the circulation of vaccinal influenza A viral strains in the biosphere]. Dokl Akad Nauk SSSR (1990) 0.75
[Evaluation of metabolic parameters in vitro as a model for testing the cytotoxicity of antiviral drugs]. Eksp Klin Farmakol (2006) 0.75
[Properties of thermostable HtpR-mutant of Escherichia coli]. Mol Gen Mikrobiol Virusol (1988) 0.75
[Synthesis of infectious viral ribonucleoproteins in isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.75